About GPhA

2010 Board of Directors & Executive Committee

Board of Directors

GPhA 2010 BOD Photo

Siobhan Barr
MDS Pharma Services Inc.

Paul Bisaro*
Watson Pharmaceuticals, Inc.

Doug Boothe
Actavis Inc.

Chuck Caprariello
Ranbaxy Pharmaceuticals

Andras Csontos
Geodeon Richter USA

Miles Davis
Sovereign Laboratories

Rosendo Ferran*
New Chemic, Inc.

Jeff Glazer
Heritage Pharmaceuticals

David Hanson
Interchem Corporation

Patrick LePore
Par Pharmaceuticals

Ed Maloney
Paddock Laboratories

William Marth*
Teva North America

Tony Mauro*
Mylan Pharmaceuticals

Paul McGarty*
Fougera (Nycomed U.S., Inc.)

Christine Mundkur*
Sandoz US, Inc.

Tom Murphy
Ben Venue Laboratories, Inc.

Joseph Renner*
Zydus Pharmaceuticals USA Inc.

Bill Seiden
Taro Pharmaceuticals USA

Tom Silberg
APP Pharmaceuticals LLC

KL Spear
Spear Pharmaceuticals

Ambrose Stafford
Apicore LLC

Vincent Ursino
Vinchem, Inc.

Craig Wheeler
Momenta Pharmaceuticals

George Zorich
Bioniche Pharma Group

* denotes member of Executive Committee

Executive Committee

Chairman
Paul Bisaro
President and CEO
Watson Pharmaceuticals, Inc.

Rosendo Ferran

Secretary/Treasurer
Rosendo Ferran
Senior Consultant
New Chemic, Inc.

Paul McGarty

Paul McGarty
CEO
Fougera (Nycomed U.S., Inc.)

Joseph Renner
President and CEO
Zydus Pharmaceuticals USA Inc.

TONY MAURO

Vice Chair
Anthony Mauro
President
Mylan Pharmaceuticals

William Marth

William Marth
President and CEO
Teva North America

Christine Mundkur
President and CEO
Sandoz US, Inc.